Workflow
海普瑞(002399) - 2023 Q3 - 季度财报
HepalinkHepalink(SZ:002399)2023-10-30 16:00

Financial Performance - Total profit decreased by 78.46% to ¥181,174,862.02 compared to ¥841,095,361.37 in the previous year[6] - Net profit fell by 78.17% to ¥141,885,482.96 from ¥650,063,599.37 year-on-year[6] - Operating profit declined by 78.76% to ¥178,819,355.74, primarily due to reduced gross profit and increased investment losses[3] - Total operating revenue for the period was CNY 4,063,233,063.48, a decrease of 24.69% compared to the same period last year[25] - Net profit attributable to shareholders of the listed company was CNY 143,170,121.26, down 78.05% year-on-year[25] - Basic earnings per share decreased by 85.97% to CNY 0.0135[25] - The company reported a net profit of CNY 141,885,482.96 for the period, a decrease of 78.05% compared to the previous year[21] Cash Flow - Cash flow from operating activities improved by 67.47%, reaching -¥233,988,970.92, compared to -¥719,281,089.84 in the previous year[7] - The company's cash flow from operating activities showed a net outflow of CNY 233,988,970.92, an increase of 67.47% compared to the same period last year[25] - The net cash flow from operating activities for the current period was -233,988,970.92 CNY, compared to -719,281,089.84 CNY in the previous period[30] - The cash inflow from other operating activities was 47,790,265.82 CNY, down from 72,009,536.97 CNY in the previous period[30] - The company reported a decrease in cash outflow for purchasing goods and services, which was 3,633,091,884.41 CNY compared to 5,322,980,702.09 CNY in the previous period[32] Assets and Liabilities - The company’s total assets decreased by 63.85% in trading financial assets, dropping to ¥474,182,329.41 from ¥1,311,642,406.30[2] - As of September 30, 2023, the company's total assets amounted to approximately CNY 20.12 billion, a decrease from CNY 20.84 billion at the beginning of the year, reflecting a decline of about 3.47%[12] - The company's current assets totaled CNY 11.86 billion, down from CNY 12.39 billion, indicating a decrease of approximately 4.29%[15] - Total liabilities amounted to CNY 7,621,518,381.46, down from CNY 8,435,034,680.42[25] - Current liabilities totaled CNY 4,997,191,595.42, down from CNY 5,575,796,301.03 at the beginning of 2023, reflecting a reduction of approximately 10.4%[39] - The total liabilities decreased to CNY 7,621,518,381.46 from CNY 8,435,034,680.42, a reduction of approximately 9.6%[39] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 27,307[8] - The largest shareholder, Shenzhen Lerun Technology Co., Ltd., holds 32.31% of the shares, totaling 474,029,899 shares[8] - The company has a total of 10 major shareholders, with Shenzhen Lerun Technology Co., Ltd. holding 474,029,899 shares, representing approximately 4.09% of the total share capital[11] Investment and Development - The company reported a significant increase in long-term equity investments, which rose to CNY 666.69 million from CNY 989.39 million, indicating a decrease of about 32.61%[15] - The company is exploring new strategies for market expansion and product development, although specific details were not disclosed in the report[14] - The company is focusing on expanding its market presence and enhancing product development capabilities to drive future growth[41] Financial Accuracy and Reporting - The report for the third quarter has not been audited[43] - The board of directors guarantees the accuracy and completeness of the financial information disclosed in the quarterly report[46] - The company has confirmed that there are no false records or misleading statements in the quarterly report[47] - The financial information in the quarterly report is stated to be true, accurate, and complete by the responsible personnel[47]